AzTrials
AzTrials

Frozen ShoulderNCT04316130

Real-time Interactive Digital Healthcare System in Frozen Shoulder; Randomized Controlled Trial

A study testing Uincare Homeplus and Brochure in people with Frozen Shoulder, run by Samsung Medical Center at 2 sites in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to examine the effect of hospital-home linkage short-term rehabilitation therapy using real-time interactive digital healthcare system (Uincare Homeplus) in frozen shoulder. This is prospective randomized controlled trial and multi-center study. Read more about this study

Who is it for?
Ages 19 years and older
Conditions the study is for
Frozen Shoulder
What is being tested?
Uincare Homeplus and Brochure
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesSouth Korea
Study dates
1 Mar 2020to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Limited passive range of motion of the affected shoulder in 2 more plane (flexion < 150˚, abduction <150˚, external rotation < 60˚)

Who cannot join

  • Bilateral frozen shoulder
  • Secondary frozen shoulder caused by trauma (shoulder fracture, dislocation), or/and inflammatory disease(rheumatoid arthritis)
  • Those unable to perform exercise due to general deconditioning
  • Those with communication difficulty

Trial locations and contacts

2 sites in 1 country.

South Korea2 sites
  • Samsung Medical Center

    Seoul, Gangnam-gu, 06351

  • Department of rehabilitation, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea

    Seoul, Seocho-gu, 06591

Other trials in South Korea

About this study

Official title: Hospital-home Linkage Short-term Rehabilitation Therapy Using Real-time Interactive Digital Healthcare System in Frozen Shoulder; Randomized Controlled Trial, Assessor Blinding, Multi-center Study

This study aims to examine the effect of hospital-home linkage short-term rehabilitation therapy using real-time interactive digital healthcare system (Uincare Homeplus) in frozen shoulder. This is prospective randomized controlled trial and multi-center study. 100 frozen shoulder who diagnosed with limited range of motion in 2 more plane of flexion, abduction, external rotation of affected shoulder. Shoulder range of motion (ROM), Shoulder Pain and Disability Index (SPADI), pain evaluation with Numeral Rating Scale (NRS), quality of life evaluation with Short Form (SF)-36 Health Survey and EQ-5D-5L, activity daily living (ADL) evaluation with Canadian Occupational Performance Measure (COPM) will be evaluated on enrollment, 4-week, 8-week, 12-weeks, 18-weeks, and 24 weeks after enrollment.

Read the detailed description

The frozen shoulder is a disease in which severe pain and limited range of motion of the shoulder occur as an inflammatory change occurs in the articular capsular surrounding the shoulder joint. As a result, it has caused limitation in daily life movement.

Uincare Homeplus is software manufactured in Korea, which uses infrared, kinect camera and motion capture technology to track 3D motion of the patients' articulation. Using this technology, the patients can receive feedback of their motion immediately.

The objective of the study is to examine the effect of hospital-home linkage short-term rehabilitation therapy using real-time interactive digital healthcare system (Uincare Homeplus) in frozen shoulder.

Conditions
Frozen Shoulder
Being tested
Uincare Homeplus, Brochure
Medical subject headings
Bursitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Uincare HomeplusDevice

    Also called digital healthcare

    Interactive digital healthcare system

  • BrochureOther

    Brochure

Study groups in NCT04316130
Study groupRoleWhat they receive
Exercise using Uincare HomeplusExperimentalUincare Homeplus
Receives: Device: Uincare Homeplus
Exercise using brochureActive comparatorbrochure
Receives: Other: Brochure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Range of motion (ROM) in affected shoulder

    Evaluation of change of ROM in the affected shoulder from baseline to 12 weeks

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

Secondary outcomes (5)
  1. Functional outcome in patients with frozen shoulder using Shoulder Pain and Disability Index (SPADI)

    Evaluation of shoulder function (pain and disability) using SPADI. Overall total scores range from 0 to 130 with a percentage score of 0 indicating less shoulder disability and 100 indicating more shoulder dysfunction.

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

  2. Numerical rating scale (NRS) of affected shoulder

    Evaluation of pain of the affected shoulder using numerical rating scale (0-10, with score 0 indicating no pain) minimum ~ maximum value: 0 ~ 10, higher scores mean worse outcome.

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

  3. Quality of life in the patients with frozen shoulder using Short form -36 (SF36)

    Evaluation of quality of life using SF36. Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

  4. Quality of life in the patients with frozen shoulder using EQ-5D-5L

    Evaluation of quality of life using EQ-5D-5L. This scale is numbered from -0.066 to 0.904. lower value means the worst quality of life you can imagine.

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

  5. Activities of Daily Living of the patients with frozen shoulder using Canadian Occupational Performance Measure (COPM)

    Evaluation of quality of life using COPM PERFORMANCE and SATISFACTION scores can be generated for up to 5 individual occupational performance problems. Average PERFORMANCE and SATISFACTION scores can be calculated by summing individual problem scores and dividing by the number of problems. Change scores for both PERFORMANCE and SATISFACTION can be calculated after a reassessment interval.

    Measured: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2020
  2. Study start1 Mar 2020
  3. Primary completion31 Dec 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04316130
Sponsor's protocol ID
SMC-2019-05-021
Status last verified
Jan 2022
First submitted
18 Mar 2020
Last updated
4 Jan 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Yeo SM, Lim JY, Kim S, Park HY, Lim JY, Do JG, Lee JI, Hwang JH. Effects of augmented reality-based telerehabilitation in adhesive capsulitis of the shoulder: a randomized controlled trial. Ann Phys Rehabil Med. 2025 Jun;68(5):101956. doi: 10.1016/j.rehab.2025.101956. Epub 2025 Jun 27.

    PubMed 40580799
  • Yeo SM, Lim JY, Do JG, Lim JY, In Lee J, Hwang JH. Effectiveness of interactive augmented reality-based telerehabilitation in patients with adhesive capsulitis: protocol for a multi-center randomized controlled trial. BMC Musculoskelet Disord. 2021 Apr 26;22(1):386. doi: 10.1186/s12891-021-04261-1.

    PubMed 33902546

Questions about this trial

What is this clinical trial studying?

A study testing Uincare Homeplus and Brochure in people with Frozen Shoulder, run by Samsung Medical Center at 2 sites in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Range of motion (ROM) in affected shoulder (time frame: Enrollment, 4 week, 8 week, 12 week, 18 weeks, 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04316130, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in